Shell Biotech Logo
SHELL BIOTECHPharmaceuticals
Back to Product Catalogue/Tablets/Newpod-200
Newpod-200
Tablets
Dispersible Tablets

Newpod-200

Cefpodoxime Proxetil Dispersible Tablets IP
Generic FormulationCefpodoxime Proxetil Dispersible Tablets IP
Dosage FormDispersible Tablets
Verified Strength200 mg
Packaging Specification10 x 10 Dispersible Tablets
Sourcing MethodPartner Pharmaceutical Manufacturing Facilities
Distribution TerritoryTelangana, India

Product Overview

Safe yet powerful broad-spectrum antibacterial with higher stability against beta-lactamases, offering proven efficacy across RTIs, sinusitis, bronchitis, pneumonia, and soft tissue infections.

Product Compliance Notice: Sourced strictly from licensed third-party pharmaceutical manufacturers. For institutional healthcare procurement and clinical inquiries only. Does not constitute consumer self-medication guidance.
PORTFOLIO

Related Formulations

Additional pharmaceutical products available for hospital and institutional supply.

New-fit
Softgels
Softgels / Syrup / Drops

New-fit

Multivitamin + Multimineral & Antioxidant

Strength:Therapeutic Nutritional Formula
Newpod-100
Suspensions
Oral Suspension / Dry Syrup

Newpod-100

Cefpodoxime Proxetil Oral Suspension IP

Strength:100 mg / 5 ml
Cold RAP
Syrups

Chlorpheniramine Maleate IP 2 mg & Phenylephrine Hydrochloride IP 5 mg

Strength:Per 5 ml: Phenylephrine HCl 5 mg, Chlorpheniramine Maleate 2 mg